Throughout the industrialized world the complications of diabetic retinopathy remain the major cause of preventable visual loss in persons of working age. A reduction by one-third or more in new blindness due to diabetes has been adopted as one of the key 5-year targets in the St Vincent declaration,1 and the best way to achieve this aim is a national strategy of screening for diabetic retinopathy. In this article we review the rationale and supporting evidence for a screening programme for diabetic retinopathy. We also debate the arguments for and against the screening modalities that are currently used in the UK.
No takes yet. Share an insight, caveat, or question.
Squirrell et al. (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: